Merck becomes bigger Alzheimer’s player, with new trial

Originally posted at December 03, 2012 (Reuters) - Merck & Co Inc has moved to the forefront of Alzheimer's disease research by starting a mid-stage study of a drug from a new class of oral medicines that aim to shut down production of a protein...

Alzheimer’s treatment research disappoints

GARY ROTSTEIN - Pittsburgh Post-Gazette, November 26, 2012 It has been a frustrating year -- a depressing decade, in fact -- for people hoping for breakthroughs in Alzheimer's research and treatment. — Two pharmaceutical giants invested...

About B.A.B.E.S.

B.A.B.E.S., “Beating Alzheimer’s by Embracing Science”, was born out of the desire for those of us who share a kindred bond to create a way to make sense and meaning of all that we have experienced, and add a bit of joy and peacefulness along our journey.